1. Eris Lifesciences
stock logo

90% Buy

Eris Lifesciences Share Price

ERIS

₹877.00+₹6.70 (0.77%) Past YearLast updated on 19 Apr, 2024 | 03:29 PM IST
₹855.00₹879.90
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹11,840 Cr

Open

₹860.00

Close

₹870.30

Circuit range

₹1,044.35 - ₹696.25

Day range

₹855.00 - ₹879.90

Year range

₹602.00 - ₹971.90

Volume

1,49,470

Avg. traded

₹870.23

Revenue (12m)

₹1,861 Cr

Eris LifesciencesEris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.

Read more

Eris Lifesciences Key indicators

arrow

52 week high

₹971.90

52 week low

₹602.00

P/E ratio

30.68

P/B ratio

4.71

ROE

19.25%

ROCE

20.54%

Dividend yield

0.84%

Debt/Equity ratio

0.14

EPS

29.27

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

90%

Hold

10%

Sell

0%

This analysis is based on the reviews of 10 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

38.1%

Net profit margin

29.02%

ROE

19.25%

ROA

17.36%

ROCE

20.54%

Learn more

Eris Lifesciences Shareholder returns

arrow

1 day

+1.54%

1 week

+2.52%

1 month

+2.63%

3 months

-4.01%

1 year

+45.24%

3 years

+47.39%

5 years

+35.76%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Eris Lifesciences Share Price history

arrow
DayOpenCloseDay’s change
Thu, Apr 18 2024
₹869.20
₹870.30
+0.13%
Tue, Apr 16 2024
₹846.00
₹867.15
+2.44%
Mon, Apr 15 2024
₹845.00
₹854.00
+1.05%
Fri, Apr 12 2024
₹846.00
₹847.35
+0.16%
Wed, Apr 10 2024
₹841.85
₹846.00
+0.49%
Tue, Apr 9 2024
₹850.05
₹842.10
-0.94%
Mon, Apr 8 2024
₹852.00
₹845.80
-0.73%
Fri, Apr 5 2024
₹839.00
₹851.35
+1.45%

Shareholding info

arrow

Promoters (54.9%)

Mutual Funds (13.85%)

Retail and other (17.41%)

Foreign institutions-FII (13.13%)

Other domestic institutions (0.72%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹7.35/share

    Ex date 11 Aug 2022

    expand tab

Learn more

Frequently asked questions